Latest News about ESMO21
Recent news which mentions ESMO21
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Tickers
APRE
From Benzinga
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
From Benzinga
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
September 20, 2021
Tickers
SYRS
From Benzinga
Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation
September 20, 2021
Tickers
EXEL
From Benzinga
Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients
September 20, 2021
Tickers
NVS
From Benzinga
AstraZeneca Touts Longest Survival Update In Lung Cancer Setting With Imfinzi/Chemo Data
September 20, 2021
From Benzinga
Mirati Unveils Long-term Survival Data For Sitravatinib/Nivolumab Combo In Lung Cancer Patients
September 20, 2021
From Benzinga
Mirati Posts Adagrasib Data In KRAS-Mutated Lung Cancer, FDA Filing Now On The Cards
September 20, 2021
Tickers
MRTX
From Benzinga
Mirati Showcases New KRAS Drug Data In Colorectal Cancer At ESMO
September 20, 2021
From Benzinga
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
September 20, 2021
Tickers
VSTM
From Benzinga
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
September 20, 2021
From Benzinga
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
September 20, 2021
From Benzinga
AstraZeneca-Daiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer
September 17, 2021
From Benzinga
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
September 17, 2021
Tickers
JNJ
From Benzinga
TCR2 Therapeutics Stock Plunges On Safety Signals From Gavo-cel Solid Tumor Trial
September 17, 2021
Tickers
TCRR
From Benzinga
Deciphera Presents New Data Across Pipeline At ESMO Congress
September 17, 2021
Tickers
DCPH
From Benzinga
Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer
September 17, 2021
Tickers
CORT
From Benzinga
What Is Happening With Innate Pharma Stock On Friday?
September 17, 2021
From Benzinga
Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer
September 17, 2021
From Benzinga
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
September 17, 2021
Tickers
NVS
From Benzinga
Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer
September 17, 2021
Tickers
AGEN
From Benzinga
Ayala Pharma Unveils New Interim Data From Rare Cancer Trial With AL101
September 16, 2021
Tickers
AYLA
From Benzinga
NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial
September 16, 2021
Tickers
NGM
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.